|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Rsus (restricted Stock Units) | $ 0 | 06/01/2013 | M | 800 | (1) | 06/01/2018 | Common Stock | 800 | $ 0 | 0 | D | ||||
Rsus (restricted Stock Units) | $ 0 | 06/01/2013 | M | 800 | (2) | 06/01/2019 | Common Stock | 800 | $ 0 | 800 | D | ||||
Rsus (restricted Stock Units) | $ 0 | 06/01/2013 | M | 1,200 | (2) | 06/01/2020 | Common Stock | 1,200 | $ 0 | 2,400 | D | ||||
Rsus (restricted Stock Units) | $ 0 | 06/01/2013 | M | 1,200 | (2) | 06/01/2021 | Common Stock | 1,200 | $ 0 | 3,600 | D | ||||
Rsus (restricted Stock Units) | $ 0 | 06/01/2013 | M | 1,200 | (2) | 06/01/2022 | Common Stock | 1,200 | $ 0 | 4,800 | D | ||||
Rsus (restricted Stock Units) | $ 0 | 06/01/2013 | A | 7,000 | (2) | 06/01/2023 | Common Stock | 7,000 | $ 0 | 7,000 | D | ||||
Sars (Stock Appreciation Rights) | $ 32.93 | 06/01/2013 | A | 15,000 | (3) | 06/01/2023 | Common Stock | 15,000 | $ 0 | 15,000 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
SHALLISH ROBERT D JR C/O CONMED CORP 525 FRENCH ROAD UTICA, NY 13502-5994 |
Vice President/Finance/CFO |
Daniel S. Jonas for Robert D. Shallish by Power of Attorney | 06/04/2013 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date. |
(2) | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date. |
(3) | The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |